Zofia Piotrowska, MD

Articles by Zofia Piotrowska, MD

OncView™ Podcast: EGFR Exon 20 Insertion as a Therapeutic Target in NSCLC

April 19th 2022

In an OncView™ program, Zofia Piotrowska, MD, touched on testing, treatment approaches, and therapeutic options for EGFR exon 20 insertion mutations in non–small cell lung cancer.

EGFR Exon 20 Insertion As A Therapeutic Target in Non-small Cell Lung Cancer

Recap: Targeted Therapies for EGFR Exon 20 Insertion-Positive NSCLC

ByZofia Piotrowska, MD

December 27th 2021

Zofia Piotrowska, MD, discusses potential therapies for patients with EGFR exon 20 insertion-positive non–small cell lung cancer.

Zofia Piotrowska, MD

Articles by Zofia Piotrowska, MD

OncView™ Podcast: EGFR Exon 20 Insertion as a Therapeutic Target in NSCLC

Recap: Targeted Therapies for EGFR Exon 20 Insertion-Positive NSCLC

Latest Updated Articles

Trending on CancerNetwork

H.R. 2541: Examining Its Legislative Impact on Radiopharmaceutical Practice

Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC

177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC

Career Stage and Location Found to Impact Oncology Coverage in the US

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC